Cargando…
Structure Based Prediction of Neoantigen Immunogenicity
The development of immunological therapies that incorporate peptide antigens presented to T cells by MHC proteins is a long sought-after goal, particularly for cancer, where mutated neoantigens are being explored as personalized cancer vaccines. Although neoantigens can be identified through sequenc...
Autores principales: | Riley, Timothy P., Keller, Grant L. J., Smith, Angela R., Davancaze, Lauren M., Arbuiso, Alyssa G., Devlin, Jason R., Baker, Brian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724579/ https://www.ncbi.nlm.nih.gov/pubmed/31555277 http://dx.doi.org/10.3389/fimmu.2019.02047 |
Ejemplares similares
-
3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
por: Devlin, Jason, et al.
Publicado: (2019) -
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023) -
Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
por: Nibeyro, Guadalupe, et al.
Publicado: (2023) -
4322 Structure-guided design of the TIL1383I T cell receptor
por: Alonso, Jesus, et al.
Publicado: (2020) -
4094 Structural Determinants of Immunogenicity for Peptide-Based Immunotherapy
por: Devlin, Jason, et al.
Publicado: (2020)